These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25301914)

  • 1. A review of current treatment strategies for restless legs syndrome (Willis-Ekbom disease).
    Klingelhoefer L; Cova I; Gupta S; Chaudhuri KR
    Clin Med (Lond); 2014 Oct; 14(5):520-4. PubMed ID: 25301914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restless legs syndrome.
    Klingelhoefer L; Bhattacharya K; Reichmann H
    Clin Med (Lond); 2016 Aug; 16(4):379-82. PubMed ID: 27481386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living with Restless Legs Syndrome/Willis-Ekbom Disease.
    Tachibana N
    Sleep Med Clin; 2015 Sep; 10(3):359-67, xv. PubMed ID: 26329446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome.
    Romero-Peralta S; Cano-Pumarega I; García-Borreguero D
    Chest; 2020 Sep; 158(3):1218-1229. PubMed ID: 32247713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the treatment of Restless Legs Syndrome/Willis-Ekbom Disease: prospects and challenges.
    Zucconi M; Galbiati A; Rinaldi F; Casoni F; Ferini-Strambi L
    Expert Rev Neurother; 2018 Sep; 18(9):705-713. PubMed ID: 30095315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.
    Silber MH; Becker PM; Earley C; Garcia-Borreguero D; Ondo WG;
    Mayo Clin Proc; 2013 Sep; 88(9):977-86. PubMed ID: 24001490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restless legs syndrome/Willis Ekbom disease: evaluation and treatment.
    Allen RP
    Int Rev Psychiatry; 2014 Apr; 26(2):248-62. PubMed ID: 24892899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
    Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
    Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willis-Ekbom Disease or Restless Legs Syndrome?
    Carlos K; Prado LB; Carvalho LB; Prado GF
    Sleep Med; 2015 Sep; 16(9):1156-9. PubMed ID: 26298794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-interval intracortical inhibition is decreased in restless legs syndrome across a range of severity.
    Magalhães SC; Queiroz de Paiva JP; Kaelin-Lang A; Sterr A; Eckeli AL; Winkler AM; Fernandes do Prado G; Amaro E; Conforto AB
    Sleep Med; 2019 Oct; 62():34-42. PubMed ID: 31539846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Diagnoses of Restless Legs Syndrome/Willis-Ekbom Disease: Mimics and Comorbidities.
    Chokroverty S
    Sleep Med Clin; 2015 Sep; 10(3):249-62, xii. PubMed ID: 26329435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).
    Ondo WG; Grieger F; Moran K; Kohnen R; Roth T
    J Clin Sleep Med; 2016 Jan; 12(1):63-70. PubMed ID: 26446245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.
    Allen R; Oertel W; Walters A; Benes H; Schollmayer E; Grieger F; Moran K; Kohnen R
    Sleep Med; 2013 Dec; 14(12):1375-80. PubMed ID: 24246378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless Legs Syndrome/Willis-Ekbom Disease and Growing Pains in Children and Adolescents.
    Simakajornboon N; Dye TJ; Walters AS
    Sleep Med Clin; 2015 Sep; 10(3):311-22, xiv. PubMed ID: 26329441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.
    Garcia-Borreguero D; Benitez A; Kohnen R; Allen R
    Postgrad Med; 2015; 127(7):716-25. PubMed ID: 26077324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
    Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
    Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rating of daytime and nighttime symptoms in RLS: validation of the RLS-6 scale of restless legs syndrome/Willis-Ekbom disease.
    Kohnen R; Martinez-Martin P; Benes H; Trenkwalder C; Högl B; Dunkl E; Walters AS
    Sleep Med; 2016 Apr; 20():116-22. PubMed ID: 27318235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Restless Legs Syndrome: from Mechanisms to Treatment.
    Gonzalez-Latapi P; Malkani R
    Curr Neurol Neurosci Rep; 2019 Jun; 19(8):54. PubMed ID: 31250128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Options in Intractable Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED).
    Rinaldi F; Galbiati A; Marelli S; Ferini Strambi L; Zucconi M
    Curr Treat Options Neurol; 2016 Feb; 18(2):7. PubMed ID: 26874840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of the restless legs Syndrome/Willis-Ekbom disease among teenagers, its clinical characteristics and impact on everyday functioning.
    Pienczk-Ręcławowicz K; Pilarska E; Olszewska A; Ręcławowicz D; Konieczna S; Sławek J
    Sleep Med; 2022 Jan; 89():48-54. PubMed ID: 34883398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.